✦ LIBER ✦

P374 Fecal transplantation in patients with moderately to severely chronic active ulcerative colitis (UC)

✍ Scribed by S. Angelberger; C. Lichtenberger; C. Gratzer; P. Papay; C. Primas; A. Eser; A. Mikulits; C. Dejaco; G. Novacek; H. Vogelsang; W. Reinisch

Book ID: 119636863
Publisher: Oxford University Press
Year: 2012
Tongue: English
Weight: 52 KB
Volume: 6
Category: Article
ISSN: 1873-9946
DOI: 10.1016/s1873-9946(12)60393-6

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

P412 Pharmacokinetics of adalimumab in a

P412 Pharmacokinetics of adalimumab in adult patients with moderately to severely active ulcerative colitis

✍ Awni, W.; Eckert, D.; Sharma, S.; Mostafa, N.; Noertersheuser, P.; Pradhan, R.; 📂 Article 📅 2013 🏛 Oxford University Press 🌐 English ⚖ 56 KB

Sa1204 Pharmacokinetics of Adalimumab in

Sa1204 Pharmacokinetics of Adalimumab in Adult Patients With Moderately to Severely Active Ulcerative Colitis

✍ Awni, Walid M.; Eckert, Doerthe; Sharma, Shringi; Mostafa, Nael M.; Noertersheus 📂 Article 📅 2013 🏛 Elsevier Science 🌐 English ⚖ 170 KB

Efficacy and safety of adalimumab in Jap

Efficacy and safety of adalimumab in Japanese patients with moderately to severely active ulcerative colitis

✍ Suzuki, Yasuo; Motoya, Satoshi; Hanai, Hiroyuki; Matsumoto, Takayuki; Hibi, Tosh 📂 Article 📅 2013 🏛 Springer Japan 🌐 English ⚖ 345 KB

Escalation to weekly dosing recaptures r

Escalation to weekly dosing recaptures response in adalimumab-treated patients with moderately to severely active ulcerative colitis

✍ Wolf, D.; D'Haens, G.; Sandborn, W. J.; Colombel, J.-F.; Van Assche, G.; Robinso 📂 Article 📅 2014 🏛 John Wiley and Sons 🌐 English ⚖ 352 KB

Predictive value of patient-reported out

Predictive value of patient-reported outcomes to mucosal healing in patients with moderately to severely active ulcerative colitis

✍ Colombel, J.F.; Han, C.; Reinisch, W.; Feagan, B.; Marano, C.; Strauss, R.; Joha 📂 Article 📅 2014 🏛 John Wiley and Sons 🌐 English ⚖ 65 KB

T1139 The ACT Trials: Incremental Benefi

T1139 The ACT Trials: Incremental Benefit of Second and Third Induction Doses of Infliximab in Patients with Moderately-to-Severely Active Ulcerative Colitis (UC)

✍ Sandborn, William J.; Rutgeerts, Paul J.; Feagan, Brian; Reinisch, Walter; Olson 📂 Article 📅 2008 🏛 Elsevier Science 🌐 English ⚖ 203 KB